Evidence map›Paper›PMID 29659606›Full record

ArticlePloS one2018

Humoral immunity to memory antigens and pathogens is maintained in patients with chronic kidney disease.

Nadezhda A Wall, C Coral Dominguez-Medina, Sian E Faustini, Charlotte N Cook, Andrew McClean, Mark D Jesky, Marisol Perez-Toledo, Matthew D Morgan, Alexandra G Richter, Charles J Ferro and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Nadezhda A WallUniversity of Birmingham, Birmingham, United Kingdom.ORCID 0000-0001-7732-3498
C Coral Dominguez-MedinaUniversity of Birmingham, Birmingham, United Kingdom.
Sian E FaustiniUniversity of Birmingham, Birmingham, United Kingdom.
Charlotte N CookUniversity of Birmingham, Birmingham, United Kingdom.
Andrew McCleanUniversity Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom.
Mark D JeskyUniversity of Birmingham, Birmingham, United Kingdom.
Marisol Perez-ToledoUniversity of Birmingham, Birmingham, United Kingdom.
Matthew D MorganUniversity of Birmingham, Birmingham, United Kingdom.
Alexandra G RichterUniversity of Birmingham, Birmingham, United Kingdom.
Charles J FerroUniversity of Birmingham, Birmingham, United Kingdom.
Paul CockwellUniversity of Birmingham, Birmingham, United Kingdom.
Paul A MossUniversity of Birmingham, Birmingham, United Kingdom.
Ian R HendersonUniversity of Birmingham, Birmingham, United Kingdom.
Lorraine HarperUniversity of Birmingham, Birmingham, United Kingdom.
Adam F CunninghamUniversity of Birmingham, Birmingham, United Kingdom.
University Hospitals Birmingham NHS Foundation Trust · GBUniversity of Birmingham · GBUniversity Hospitals of North Midlands NHS Trust · GB

Funding

Medical Research Council MR/N023706/1Medical Research Council MR/N027027/1Wellcome Trust
6 · The paper itself

Abstract

Patients with chronic kidney disease (CKD) have an increased risk of infection and poorer responses to vaccination. This suggests that CKD patients have an impaired responsiveness to all antigens, even those first encountered before CKD onset. To examine this we evaluated antibody responses against two childhood vaccine antigens, tetanus (TT) and diphtheria toxoids (DT) and two common pathogens, cytomegalovirus (CMV) and Salmonella enterica serovar Enteritidis (SEn) in two independent cohorts consisting of age-matched individuals with and without CKD. Sera were evaluated for antigen-specific IgG titres and the functionality of antibody to SEn was assessed in a serum bactericidal assay. Surprisingly, patients with CKD and control subjects had comparable levels of IgG against TT and DT, suggesting preserved humoral memory responses to antigens encountered early in life. Lipopolysaccharide-specific IgG titres and serum bactericidal activity in patients with CKD were also not inferior to controls. CMV-specific IgG titres in seropositive CKD patients were similar or even increased compared to controls. Therefore, whilst responses to new vaccines in CKD are typically lower than expected, antibody responses to antigens commonly encountered prior to CKD onset are not. The immunodeficiency of CKD is likely characterised by failure to respond to new antigenic challenges and efforts to improve patient outcomes should be focussed here.

Indexed as

Immunity, HumoralImmunologic MemoryAgedAntibodies, BacterialAntigensBiomarkersFemaleHost-Pathogen InteractionsHumansImmunoglobulin GInfectionsMaleMiddle AgedRenal Insufficiency, ChronicAntibodies, BacterialAntigensBiomarkersImmunoglobulin G

Identifiers

PMID29659606
PMCPMC5901993
OpenAlexW2800163364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.